AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 100 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $10,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,382,735 | $73,076,000 | 20.10% |
| Redmile Group, LLC | 699,070 | $37,750,000 | 4.11% |
| Ghost Tree Capital, LLC | 125,000 | $6,750,000 | 3.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,614,669 | $87,192,000 | 3.13% |
| Green Owl Capital Management, LLC | 26,000 | $1,404,000 | 1.26% |
| COWEN INC. | 248,674 | $13,428,000 | 1.06% |
| RTW INVESTMENTS, LP | 50,000 | $2,700,000 | 1.00% |
| Cormorant Asset Management, LP | 65,000 | $3,510,000 | 0.54% |
| Tourbillon Capital Partners, L.P. | 330,000 | $17,820,000 | 0.48% |
| QVT Financial LP | 108,000 | $5,832,000 | 0.29% |